Research on Quality of Life in Female Patients with Congenital Adrenal Hyperplasia and Issues in Developing Nations

Journal of Pediatric and Adolescent Gynecology

Volumn 26, Issue 6, 2013, Pages 296-304

  Zainuddin, Ani Amelia ^a   Grover, Sonia R ^b   Shamsuddin, Khadijah ^a   Mahdy, Zaleha Abdullah ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Ambiguous genitalia; Congenital adrenal hyperplasia; Disorder of sex development; Endocrine; Feminizing genitoplasty; Gender Identity; Quality of life

Indexed keywords

ESTROGEN; GLUCOCORTICOID; INSULIN; STEROID 21 MONOOXYGENASE;

ADRENAL CORTEX INSUFFICIENCY; ADULT DISEASE; AMBIGUOUS GENITALIA; CHILDHOOD DISEASE; CLITORAL PAIN; CLITOROPLASTY; CONGENITAL ADRENAL HYPERPLASIA; CORTICOSTEROID THERAPY; DELAYED DIAGNOSIS; ESTROGEN SYNTHESIS; FEMALE; FEMALE GENITAL MUTILATION TYPE I; FEMALE GENITAL PAIN; FEMALE INFERTILITY; FEMALE SEXUAL DYSFUNCTION; FIBROSIS; GENDER IDENTITY; HEMATOCOLPOS; HUMAN; INSULIN RESISTANCE; MALAYSIA; OBESITY; PEDIATRIC SURGERY; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REOPERATION; SALT WASTING; SCAR FORMATION; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SHORT FORM 36; SHORT STATURE; SHORT SURVEY; STENOSIS; STEROID 21 MONOOXYGENASE DEFICIENCY; URETHRA STRICTURE; URINARY TRACT FISTULA; URINARY TRACT INFECTION; URINE INCONTINENCE; UROGENITAL SINUS; VAGINA RECONSTRUCTION; VAGINAL FIBROSIS; VAGINAL STENOSIS; VIET NAM; VIRILIZATION; WELLBEING;

AMBIGUOUS GENITALIA; CONGENITAL ADRENAL HYPERPLASIA; DISORDER OF SEX DEVELOPMENT; ENDOCRINE; FEMINIZING GENITOPLASTY; GENDER IDENTITY; QUALITY OF LIFE;

ADRENAL HYPERPLASIA, CONGENITAL; DEVELOPING COUNTRIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALAYSIA; PATIENT SATISFACTION; QUALITY OF LIFE; TREATMENT OUTCOME; VIETNAM;

EID: 84887616564     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2012.08.004     Document Type: Short Survey

References (110)

1. Speiser P.W., White P.C. Congenital adrenal hyperplasia. N Engl J Med 2003, 349:776.
2. Nordenström A., Ahmed S., Jones J., et al. Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening. Horm Res 2005, 63:22.
3. Pang S., Shook M.K. Current status of neonatal screening for congenital adrenal hyperplasia. Curr Opin Pediatr 1997, 9:419.
4. Therrell B.L. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001, 30:15.
5. van der Kamp H.J., Wit J.M. Neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol 2004, 151(Suppl 3):U71.
6. Lee P.A., Houk C.P., Ahmed S.F., et al. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology: Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006, 118:e488.
7. Hagenfeldt KB. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - the adult woman. Growth Hormone & IGF Research 14 (2004) S67-S71. http://dx.doi.org/10.1016/j.ghir.2004.03.016.
8. Ogilvie C.M., Crouch N.S., Rumsby G., et al. Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Clin Endocrinol (Oxf) 2006, 64:2.
9. Hughes I.A., Nihoul-Fékété C., Thomas B., et al. Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res Clin Endocrinol Metab 2007, 21:351.
10. Riepe F.G., Sippell W.G. Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Rev Endocr Metab Disord 2007, 8:349.
11. Speiser P.W. Growth and development: congenital adrenal hyperplasia-glucocorticoids and height. Nat Rev Endocrinol 2010, 6:14.
12. New M.I. Prevention of ambiguous genitalia by prenatal treatment with dexamethasone in pregnancies at risk for congenital adrenal hyperplasia. Pure Appl Chem 2003, 75(11-12):2013.
13. Krege S., Walz K.H., Hauffa B.P., et al. Long-term follow-up of female patients with congenital adrenal hyperplasia from 21-hydroxylase deficiency, with special emphasis on the results of vaginoplasty. BJU Int 2000, 86:253.
14. Rink R.C., Adams M.C. Feminizing genitoplasty: state of the art. World J Urol 1998, 16:212.
15. Hutson J., Voight R.W., Luthra M., et al. Girth-reduction clitoroplasty - a new technique: experience with 37 cases. Pediatr Surg Int 1991, 6:336.
16. Chia W.Y. Tissue-preserving feminizing clitoroplasty: a preliminary report. JPediatr Urol 2007, 3:457.
17. Pippi-Salle J.L., Braga L.P., Macedo N., et al. Corporeal sparing dismembered clitoroplasty: an alternative technique for feminizing genitoplasty. J Urol 2007, 178(4 Pt 2):1796.
18. Fortunoff S.T., Lattimer J.K., Edson M. Vaginoplasty technique for female pseudohermaphrodites. Surg Gynecol Obstet 1964, 118:545.
19. Hendren W.H., Crawford J.D. Adrenogenital syndrome: The anatomy of the anomaly and its repair. Some new concepts. J Pediatr Surg 1969, 4:49.
20. Passerini-Glazel G. A new 1-stage procedure for clitorovaginoplasty in severely masculinized female pseudohermaphrodites. J Urol 1989, 142(2Pt2):565.
21. Peña A., Filmer B., Bonilla E., et al. Transanorectal approach for the treatment of urogenital sinus: preliminary report. J Pediatr Surg 1992, 27:681.
22. Hendren W.H. Urogenital sinus and cloacal malformation. Semin Pediatr Surg 1996, 5:72.
23. Rink R.C., Pope J.C., Kropp B.P., et al. Reconstruction of the high urogenital sinus: early perineal prone approach without division of the rectum. J Urol 1997, 158:1293.
24. Peña A. Total urogenital mobilization-an easier way to repair cloacas. JPediatr Surg 1997, 32:263.
25. Rink R.C., Metcalfe P.D., Kaefer M.A., et al. Partial urogenital mobilization: a limited proximal dissection. J Pediatr Urol 2006, 2:351.
26. Donahoe P.K., Gustafson M.L. Early one-stage surgical reconstruction of the extremely high vagina in patients with congenital adrenal hyperplasia. JPediatr Surg 1994, 29:352.
27. de Jong T.P., Boemers T.M. Neonatal management of female intersex by clitorovaginoplasty. J Urol 1995, 154:830.
28. Schnitzer J.J., Donahoe P.K. Surgical treatment of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. [Review] 2001 Mar, 30(1):137-154.
29. Hendren W.H., Donahoe P.K. Correction of congenital abnormalities of the vagina and perineum. J Pediatr Surg 1980, 15:751.
30. Farkas A., Chertin B. Feminizing genitoplasty in patients with 46XX congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2001, 14:713.
31. Jenak R., Ludwikowski B., Gonzalez R. Total urogenital sinus mobilization: a modified perineal approach for feminizing genitoplasty and urogenital sinus repair. J Urol 2001, 165:2347.
32. Ganesan A., Smith G.H., Broome K., et al. Congenital adrenal hyperplasia: preliminary observations of the urethra in 9 cases. J Urol 2002, 167:275.
33. Braga L.H., Silva I.N., Tatsuo E.S. [Total urogenital sinus mobilization in the repair of ambiguous genitalia in children with congenital adrenal hyperplasia]. Arq Bras Endocrinol Metabol 2005, 49:908.
34. Rink R.C., Metcalfe P.D., Cain M.P., et al. Use of the mobilized sinus with total urogenital mobilization. J Urol 2006, 176:2205.
35. Savanelli A., Alicchio F., Esposito C., et al. A modified approach for feminizing genitoplasty. World J Urol 2008, 26:517.
36. Farhat W.A. Early intervention of CAH surgical management. J Pediatr Adolesc Gynecol 2005, 18:66.
37. Passerini-Glazel G. Feminizing genitoplasty [comment]. J Urol 1999, 161:1592.
38. Gearhart J.P. Editorial comment. BJU Int 2000, 86:258.
39. Gonzalez R., Fernandez E.T. Single-stage feminization genitoplasty. J Urol 1990, 143:776.
40. Hanza A.F., Soliman H.A., Abdel Hay S.A., et al. Total urogenital sinus mobilization in the repair of cloacal anomalies and congenital adrenal hyperplasia. J Pediatr Surg 2001, 36:1656.
41. Oesterling J.E., Gearhart J.P., Jeffs R.D. A unified approach to early reconstructive surgery of the child with ambiguous genitalia. J Urol 1987, 138:1079.
42. Snyder H.M., Retik A.B., Bauer S.B., et al. Feminizing genitoplasty: a synthesis. J Urol 1983, 129:1024.
43. Hendren W.H., Atala A. Repair of the high vagina in girls with severely masculinized anatomy from the adrenogenital syndrome. J Pediatr Surg 1995, 30:91.
44. Burgu B., Duffy P.G., Cuckow P., et al. Long-term outcome of vaginal reconstruction: comparing techniques and timing. J Pediatr Urol 2007, 3:316.
45. Eroǧlu E., Tekant G., Gündoǧdu G., et al. Feminizing surgical management of intersex patients. Pediatr Surg Int 2004, 20:543.
46. Lean W.L., Deshpande A., Hutson J., et al. Cosmetic and anatomic outcomes after feminizing surgery for ambiguous genitalia. J Pediatr Surg 1856, 2005:40.
47. Crawford J.M., Warne G., Grover S., et al. Results from a pediatric surgical centre justify early intervention in disorders of sex development. J Pediatr Surg 2009, 44:413.
48. Gastaud F., Bouvattier C., Duranteau L., et al. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. JClin Endocrinol Metab 2007, 92:1391.
49. Göllü G., Yildiz R.V., Bingol-Kologlu M., et al. Ambiguous genitalia: an overview of 17 years' experience. J Pediatr Surg 2007, 42:840.
50. Minto C.L., Liao L.M., Woodhouse C.R., et al. The effect of clitoral surgery on sexual outcome in individuals who have intersex conditions with ambiguous genitalia: a cross- sectional study. Lancet 2003, 361:1252.
51. Creighton S.M., Minto C.L., Steele S.J. Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. Lancet 2001, 358:124.
52. Warne G.L., Zajac J.D. Disorders of sexual differentiation. Endocrinol Metab Clin North Am 1998, 4:945.
53. Creighton S.M., Farhat W.A. Early versus late intervention of congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol. [Corrected and Republished Article] 2005 Feb, 18(1):63-69.
54. Creighton S.M., Liao L.M. Changing attitudes to sex assignment in intersex. BJU Int 2004, 93:659.
55. Glassberg K.I. Gender assignment and the pediatric urologist. J Urol. [Comment Editorial] 1999 Apr, 161(4):1308-1310.
56. Braga L.H., Pippi Salle J.L. Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment. Eur J Pediatr Surg 2009, 19:203.
57. Merke D.P., Bornstein S.R. Congenital adrenal hyperplasia. Lancet 2005, 365:2125.
58. Farkas A., Chertin B., Hadas-Halpren I. 1-Stage feminizing genitoplasty: 8 years of experience with 49 cases. J Urol 2001, 165(6 Pt 2):2341.
59. Graziano K., Teitelbaum D.H., Hirschl R.B., et al. Vaginal reconstruction for ambiguous genitalia and congenital absence of the vagina: a 27-year experience. J Pediatr Surg 2002, 37:955.
60. ISNA'S Recommendations for Treatment at . Intersex Society of North America 1994. http://www.isna.org/node/138.
61. Chase C. Hermaphrodites with attitude: mapping the emergence of intersex political activism. GLQ 1998, 4:189.
62. Lobe T.E., Woodall D.L., Richards G.E., et al. The complications of surgery for intersex: changing patterns over two decades. J Pediatr Surg 1987, 22:651.
63. Alizai N.K., Thomas D.F., Lilford R.J., et al. Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty?. J Urol 1999, 161:1588.
64. Creighton S.M. Long-term outcome of feminization surgery: the London experience. BJU Int 2004, 93(Suppl 3):44.
65. Davies M.C., Crouch N.S., Woodhouse C.R., et al. Congenital adrenal hyperplasia and lower urinary tract symptoms. BJU Int 2005, 95:1263.
66. Cull M. Commentary: A support group's perspective. BMJ 2005, 330:341.
67. Hines M., Brook C., Conway G.S. Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). JSex Res 2004, 41:75.
68. Dittmann R.W., Kappes M.H., Kappes M.E., et al. Congenital adrenal hyperplasia. I: Gender-related behavior and attitudes in female patients and sisters. Psychoneuroendocrinology 1990, 15:401.
69. Dittmann R.W., Kappes M.H., Kappes M.E., et al. Congenital adrenal hyperplasia. II: Gender-related behavior and attitudes in female salt-wasting and simple-virilizing patients. Psychoneuroendocrinology 1990, 15:421.
70. Meyer-Bahlburg H.F., Gruen R.S., New M.I., et al. Gender change from female to male in classical congenital adrenal hyperplasia. Horm Behav 1996, 30:319.
71. Zucker K.J., Bradley S.J., Oliver G., et al. Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav 1996, 30:300.
72. Berenbaum S., Hines M. Early androgens are related to childhood sex-typed toy preferences. Psychol Sci 1992, 3:203.
73. Nordenstrom A., Servin A., Bohlin G., et al. Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2002, 87:5119.
74. Ehrhardt A.A., Epstein R., Money J. Fetal androgens and female gender identity in the early-treated adrenogenital syndrome. Johns Hopkins Med J 1968, 122:160.
75. Ehrhardt AA, Baker SW: Fetal androgens, human central nervous system differentiation, and behaviour sex differences. In: Sex differences in behavior. Edited by RC Friedman, RR Richart, LVande Wiele. New York, Wiley, pp 33-51.
76. Hines M., Kaufman F.R. Androgen and the development of human sex-typical behavior: rough-and-tumble play and sex of preferred playmates in children with congenital adrenal hyperplasia (CAH). Child Dev 1994, 65:1042.
77. Money J., Schwartz M., Lewis V.G. Adult erotosexual status and fetal hormonal masculinization and demasculinization: 46, XX congenital virilizing adrenal hyperplasia and 46, XY androgen-insensitivity syndrome compared. Psychoneuroendocrinology 1984, 9:405.
78. Dittmann R.W., Kappes M.E., Kappes M.H. Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Psychoneuroendocrinology 1992, 17:153.
79. Gupta D.K., Shilpa S., Amini A.C., et al. Congenital adrenal hyperplasia: long-term evaluation of feminizing genitoplasty and psychosocial aspects. Pediatr Surg Int 2006, 22:905.
80. Otten B.J., Stikkelbroeck M.M., Claahsen-van der Grinten H.L., et al. Puberty and fertility in congenital adrenal hyperplasia. Endocr Dev 2005, 8:54.
81. Meyer-Bahlburg H.F. What causes low child-bearing in congenital adrenal hyperplasia?. J Clin Endocrinol Metab 1844, 1999:84.
82. Warren G. Congenital adrenal hyperplasia: long-term outcome studies. Endocrinologist 2003, 13:179.
83. Bhanji R., Khan A.H., Balouch I.L., et al. Profile of children with congenital adrenal hyperplasia-a hospital study. J Pak Med Assoc 2004, 54:509.
84. Bhansali A., Singh R., Sriram M., et al. Disorders of sex development: a study of ninety-five patients. Endocrinologist 2009, 19:98.
85. Warne G.L., Raza J. Disorders of sex development (DSDs), their presentation and management in different cultures. Rev Endocr Metab Disord 2008, 9:227.
86. Ammini A.C., Gupta R., Kapoor A., et al. Etiology, clinical profile, gender identity, and long-term follow up of patients with ambiguous genitalia in India. JPediatr Endocrinol Metab 2002, 15:423.
87. Rajendran R., Hariharan S. Profile of intersex children in South India. Indian Pediatr 1995, 32:666.
88. Joshi R.R., Rao S., Desai M. Etiology and clinical profile ambiguous genitalia: an overview of 10 years experience. Indian Pediatr 2006, 43:974.
89. Chatterjee S., Chatterjee S.K. Congenital adrenal hyperplasia: experience at Calcutta. Indian Pediatr 1992, 29:1013.
90. Menon P.S., Harinarayan C.V., Forest M.G. Congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Indian Pediatr 1992, 29:98.
91. Armstrong K.L., Henderson C., Hoan N.T., et al. Living with congenital adrenal hyperplasia in Vietnam: a survey of parents. J Pediatr Endocrinol Metab 2006, 19:1207.
92. WHO Division of Mental Health. WHO-QOL study protocol: The development of the World Health Organization quality-of-life assessment instrument 1993, Geneva, United Nations.
93. Janssen OE, Hahn S, Elsenbruch S: Psychosocial and quality-of-life consequences of androgen excess and the polycystic ovary syndrome. In: Azziz R, editor. Contemporary Endocrinology: Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and Other Disorders, (2nd ed.). Edited by R Azziz, JE Nesler, D Dewailly. Totowa, NJ, Humana Press, 2006, pp 343-352.
94. Hasanah C.I. Approaches and methodological as well as interpretative issues in quality of life research in Malaysia. Malaysian J Med Sci 2003, 10:60.
95. Guyatt G.H., Feeny D.H., Patrick D.L. Measuring health-related quality of life. Ann Intern Med 1993, 118:622.
96. Malouf M.A., Inman A.G., Carr A.G., et al. Health-related quality of life, mental health and psychotherapeutic considerations for women diagnosed with a disorder of sexual development: congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010, 2010. 253465.
97. Johannsen T.H., Ripa C.P., Mortensen E.L., et al. Quality of life in 70 women with disorders of sex development. Eur J Endocrinol 2006, 155:877.
98. Kuhnle U., Bullinger M., Schwarz H.P. The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. Eur J Pediatr 1995, 154:708.
99. Kuhnle U., Bullinger M. Outcome of congenital adrenal hyperplasia. Pediatr Surg Int 1997, 12:511.
100. Frisen L., Nordenström A., Falhammar H., et al. Gender role behaviour, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J Clin Endocrinol Metab 2009, 94:3432.
101. Jääskeläinen, Voutilainen R. Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr 2000, 89:183.
102. Warne G., Grover S., Hutson J., et al. A long-term outcome study of intersex conditions. J Pediatr Endocrinol Metab 2005, 18:555.
103. Reisch N., Hahner S., Bleicken B. Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency. Clin Endocrinology (Oxf) 2011, 74:166.
104. Arlt W., Willis D.S., Wild S.H., et al. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 2010, 95:5110.
105. Nordenskjöld A., Holmdahl G., Frisén L., et al. Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2008, 93:380.
106. Berenbaum S.A., Korman Bryk K., Duck S.C., et al. Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 2004, 144:741.
107. Morgan J.F., Murphy H., Lacey J.H., et al. Long term psychological outcome for women with congenital adrenal hyperplasia: cross sectional survey. BMJ 2005, 330(7487):340.
108. Lee P.A., Houk C.P. The role of support groups, advocacy groups, and other interested parties in improving the care of patients with congenital adrenal hyperplasia: pleas and warnings. Int J Pediatr Endocrinol 2010, 2010:563640.
109. Brain C.E., Creighton S.M., Mushtaq I., et al. Holistic management of DSD. Best Pract Res Clin Endocrinol Metab 2010, 24:335.
110. Clayton P.E., Miller W.L., Oberfield S.E., et al. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002, 58:188.